|1.||Mueck, Alfred O: 5 articles (05/2013 - 07/2002)|
|2.||Seeger, Harald: 4 articles (05/2013 - 07/2002)|
|3.||Lidegaard, Øjvind: 3 articles (10/2014 - 01/2009)|
|4.||Seeger, H: 3 articles (01/2006 - 11/2001)|
|5.||Mueck, A O: 3 articles (01/2006 - 11/2001)|
|6.||Wallwiener, D: 3 articles (01/2006 - 11/2001)|
|7.||Wallwiener, Diethelm: 3 articles (07/2005 - 07/2002)|
|8.||Liang, Yayun: 2 articles (05/2013 - 09/2010)|
|9.||Hyder, Salman M: 2 articles (05/2013 - 09/2010)|
|10.||Løkkegaard, Ellen: 2 articles (06/2012 - 01/2009)|
02/01/2014 - "Twenty patients required norethindrone taper for heavy bleeding; of this group 78.9% experienced complete cessation of bleeding within 7 days. "
02/01/2014 - "Our objectives were to review norethindrone use in an adolescent population in a tertiary care center and to assess the effectiveness of the norethindrone taper in the management of acute heavy menstrual bleeding in adolescents. "
03/01/2010 - "A withdrawal bleed within a few days of stopping the norethisterone indicates the presence of oestrogen and bleeding more than a few drops is considered a positive withdrawal bleed. "
02/01/1995 - "If the endometrial thickness on the onset of progestogen addition was 5 mm or more, in nearly all cases withdrawal bleeding occurred when MPA or norethisterone was used. "
11/01/1980 - "Effect of norethisterone on puerperal vaginal bleeding."
08/01/1992 - "The role of norethindrone as a supplement to GnRHa in eliminating such side effects was assessed by enrolling 20 patients with symptomatic endometriosis diagnosed laparoscopically in a randomized, prospective, double-blinded trial. "
01/01/1964 - "CELIOSCOPIC STUDY OF WOMEN TREATED WITH CYCLIC NORETHISTERONE FOR ENDOMETRIOSIS."
10/01/1995 - "Norethindrone is effective as add-back in the management of endometriosis but not leiomyomata, although high doses alter lipid profiles in an undesirable fashion. "
08/01/1992 - "The addition of norethindrone to GnRHa is an effective means of treating symptomatic endometriosis while ameliorating side effects induced by GnRHa alone."
08/01/2000 - "Domestic LHRH-a combined with low-dose norethindrone was effective in the treatment of endometriosis. "
01/01/2015 - "She had used norethisterone to postpone her menstruation and presented to our institution with severe menorrhagia. "
04/01/2008 - "The regimen of TA 3 g daily during menstrual days 1-5 is a more effective and tolerable treatment than luteal phase norethisterone for patients with ovulatory menorrhagia."
05/01/1995 - "Norethisterone at this dose is not effective therapy for ovulatory menorrhagia."
11/01/2010 - "Continuous high-dose (10 to 20 mg/day) continuous norethisterone to treat menorrhagia in adolescents and young women with bleeding disorders is inadvisable. "
11/01/1993 - "Our purpose was to compare the efficacy of the recommended dose of danazol, a reduced-dose danazol regimen, and norethindrone in the treatment of objectively proven menorrhagia. "
04/01/1987 - "We conclude that norethindrone is an effective treatment for mild hyperparathyroidism in postmenopausal women."
09/01/1990 - "Treatment of postmenopausal hyperparathyroidism with norethindrone. "
04/01/1987 - "Treatment of postmenopausal hyperparathyroidism with norethindrone. "
02/01/1989 - "Norethisterone can inhibit bone resorption and has recently been shown to be effective treatment for mild hyperparathyroidism in post menopausal women. "
06/05/1986 - "To assess the effect of these sex steroids in patients with primary hyperparathyroidism, we treated postmenopausal women who had hyperparathyroidism with either ethinyl estradiol (n = 6) or norethindrone (n = 11). "
|5.||Breast Neoplasms (Breast Cancer)
05/01/1993 - "Oestrogens are known to stimulate the growth of human breast cancer cells, and this laboratory has previously reported (Jeng & Jordan, 1991) that the 19-norprogestin norethindrone could stimulate the proliferation of MCF-7 human breast cancer cells. "
09/01/1982 - "Twenty-six patients with advanced breast cancer and progressive disease were treated by norethisterone. "
03/19/1968 - "[Results of norethindrone (norluten) treatment of diffusion phase breast cancer]."
01/01/1974 - "18 French women with bone metastases of breast cancer were treated with norethisterone 60 mg per day (except 1 woman given 20 mg daily) for 2 months or until the end of the remission from 1969-1972. "
05/01/2013 - "Clinical trials have demonstrated an increased risk of breast cancer during estrogen/norethisterone (NET) therapy. "
|1.||Levonorgestrel (Plan B)
|2.||Ethinyl Estradiol (Estinyl)
|3.||Gonadotropin-Releasing Hormone (GnRH)
|4.||estradiol valerate (Delestrogen)
|6.||Tranexamic Acid (AMCA)
|7.||Mefenamic Acid (Pontal)
|1.||Intrauterine Devices (Intrauterine Device)
|2.||Female Contraceptive Devices (Vaginal Ring)
|3.||Platelet Transfusion (Blood Platelet Transfusions)
|5.||Contraception (Birth Control)